🇺🇸 FDA
Patent

US 8916606

Therapeutic compositions and methods for targeted delivery of active agents

granted A61KA61K47/6929A61K47/6949

Quick answer

US patent 8916606 (Therapeutic compositions and methods for targeted delivery of active agents) held by The Board of Regents of the University of Texas System expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K47/6929, A61K47/6949, A61K51/1268, A61P